Home›Stock Screener›Samsrita Labs

Samsrita Labs Share Price Today | Stock Price & Samsrita Labs Share Screener

SAMSRITA Healthcare Services
Live Share Price BSE
₹12.49
▲ 0.60 (5.05%)
2026-11-18 00:00:00

As of November 18, 2026, the live Samsrita Labs share price (BSE: SAMSRITA) is ₹12.49, up 5.05% from the previous close, with shares trading between ₹11.80 and ₹12.49 in today's trading session, and a 52-week range of ₹10.60–₹23.99. Track Samsrita Labs networth to gauge the company's total market size. Use the Samsrita Labs stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Samsrita Labs opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Samsrita Labs Market Cap ₹27.23 Cr.
SAMSRITA P/E Ratio (TTM) -7.10
Samsrita Labs P/B Ratio 2.44
EPS (TTM) ₹-3.99
Dividend Yield -
Debt to Equity 0.17
SAMSRITA 52 Week High ₹23.99
Samsrita Labs 52 Week Low ₹10.60
Operating Margin -
Profit Margin -
SAMSRITA Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹14.00
Total Equity ₹12.00

Samsrita Labs Share Price Chart

Track the current stock price of Samsrita Labs with an interactive chart. Analyse SAMSRITA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Samsrita Labs stock quote in one place.

The quote of ₹12.49 sits between the 52-week low of ₹10.60 and the 52-week high of ₹23.99, and the latest session moved 5.05% from the previous close.

Samsrita Labs Company Profile - Fundamental Screener

Screen Samsrita Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SAMSRITA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE579N01018.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE579N01018

Samsrita Labs Balance Sheet Screener

Screen SAMSRITA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹14, down from ₹16 in 2025.

Latest statistics put total assets at ₹14 and shareholder funds at ₹12, with a leverage ratio of 0.17.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 14 16 16 16 17 17 28 26 23 19
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 1

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 12 12 12 13 13 11 16 16 16 12
Share Capital 23 15 15 15 15 15 15 14 12 10
Reserves & Surplus -11 -3 -3 -2 -2 -4 -3 -2 -2 -2

Samsrita Labs Income Statement Screener - Profit & Revenue Analysis

Screen Samsrita Labs income statement and profit fundamentals. Analyze SAMSRITA quarterly results. Samsrita Labs reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹0 and net profit was ₹0, equal to earnings per unit of ₹-0.12.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-Jun, shows revenue of ₹0 and net profit of ₹0.

Item 2026-Sept 2026-Jun 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2021-Sept 2021-Jun 2021-Mar 2020-Dec 2020-Sept 2020-Jun 2020-Mar

Revenue and Expenses

Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 3 5 0 0 0 0 0 0 0 0 0 1

Operating Costs and Margins

EBITDA 0 0 0 -3 -5 0 0 0 0 0 0 0 0 0 -1
Operating Profit % 0.00% 0.00% -750.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -3100.00% -221.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0 -3 -5 0 0 0 0 0 0 0 0 0 -1
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 -1 -3 -5 0 0 0 0 0 0 0 0 0 0
EPS -0.12 -0.08 -0.06 -1.29 -2.00 0.00 0.00 0.00 -0.02 -0.03 0.09 -0.13 -0.19 -0.19 -0.26

Samsrita Labs Cash Flow Screener - Liquidity Fundamentals

Screen SAMSRITA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹4, and net cash flow was an inflow of ₹2.

Over the same period, investing activities provided ₹3 and financing activities provided ₹3.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities -4 0 0 1 0 0 -1 -3 -3 0
Investing Activities 3 0 0 0 0 0 -1 -2 -1 -1

Financing and Net Cash

Financing Activities 3 0 0 -1 0 1 2 4 5 1
Net Cash Flow 2 0 0 0 0 0 0 0 0 0

Samsrita Labs Shareholding Pattern Screener

See Samsrita Labs shareholding pattern with promoter, FII, and DII holdings. Check Samsrita Labs promoter holding and ownership changes for SAMSRITA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 25.44%, foreign institutions 0.00%, domestic institutions 0.00% and the public 70.48%, spread across 2,441 shareholders.

The shareholder count was 2,441 in 2026-Mar, compared with 2,506 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Jul 2025-Sept 2025-Dec

Promoter Holding

Promoter Holding 25.44% 25.44% 25.44% 49.27% 48.25% 31.41% 31.41% 25.44%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 70.48% 70.43% 70.27% 44.75% 45.58% 64.57% 64.54% 70.50%
Other Holding 4.08% 4.14% 4.30% 5.99% 6.17% 4.02% 4.05% 4.06%
Shareholder Count 2,441 2,506 2,548 2,608 2,478 2,499 2,441 2,436

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Samsrita Labs. Samsrita Labs dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Samsrita Labs.

Samsrita Labs Stock Index Membership - Nifty & Sensex

See which indices include Samsrita Labs stock. Check SAMSRITA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Samsrita Labs is not part of any tracked indices.
Only major market indices are tracked in our system.

Samsrita Labs Market Events Screener - Corporate Actions

Get Samsrita Labs corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Samsrita Labs stock events that may affect SAMSRITA share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 11, 2026, with a record date of November 11, 2026.

It is followed by Extraordinary General Meeting dated October 26, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-11 2026-11-11 Quarterly Result Announcement NA -3.93%
2026-10-26 2026-10-26 Extraordinary General Meeting NA 8.14%
2026-08-13 2026-08-13 Quarterly Result Announcement NA 5.14%
2026-08-10 2026-08-10 Annual General Meeting NA -2.48%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -12.93%
2026-02-06 2026-02-06 Quarterly Result Announcement NA 7.85%
2025-10-25 2025-10-25 Quarterly Result Announcement NA 8.11%
2025-08-25 2025-08-25 Annual General Meeting NA 13.66%
2025-07-18 2025-07-18 Quarterly Result Announcement NA -7.67%
2025-05-23 2025-05-23 Extraordinary General Meeting NA -1.25%
2025-04-26 2025-04-26 Quarterly Result Announcement NA 27.43%
2025-01-06 2025-01-06 Quarterly Result Announcement NA -0.04%
2024-11-11 2024-11-11 Quarterly Result Announcement NA -2.06%
2024-09-21 2024-09-21 Annual General Meeting NA 57.70%
2022-08-10 2022-08-10 Change Of Name NA 0.00%

Samsrita Labs Competitors Screener - Peer Stocks Comparison

Screen SAMSRITA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 126,293 53.90 25,420 15.58% 2,003 64.36
Max Healthcare Institute 100,061 71.20 8,536 18.82% 1,442 73.63
Manipal Health Enterprises 93,576 104.20 10,521 25.80% 917 58.01
Aster DM Quality Care 64,892 116.10 4,769 11.25% 427 61.53
Fortis Healthcare 60,869 57.00 9,179 16.93% 1,064 56.49
Global Health 38,884 62.80 4,509 19.56% 554 63.26
Narayana Hrudayalaya 38,841 45.00 7,996 43.43% 811 60.17
Dr. Lal Path Labs 33,662 57.20 2,864 12.11% 510 57.81
Krishna Institute of Medical Sciences 32,099 163.00 3,931 28.16% 242 65.46
Syngene International 17,586 95.70 3,809 2.56% 317 66.04

Samsrita Labs Company Announcements - News & Reports Screener

Screen SAMSRITA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 15, 2026.

The next most recent announcements are dated November 14, 2026 and November 14, 2026.

Date Update Actions
2026-11-15 Newspaper Publication -
2026-11-14 Statement Of Deviation /Variation For The Quarter Ended 30.09.2026 -
2026-11-14 Board Meeting Outcome for Ooutcome For Board Meeting Held On 11.11.2026 -
2026-11-14 Un-Audited Financial Results (Standalone And Consolidated)For The Quarter Ended 30Th September 2026 -
2026-11-03 Board Meeting Intimation for Meeting To Be Held On 11.11.2026 -
2026-10-26 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-10-26 Shareholder Meeting / Postal Ballot-Outcome of EGM -
2026-10-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-10 Announcement Under Regulation 30(LODR)- Intimation Regarding Alteration Of Memorandum Of Association Of The Company -
2026-10-04 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-10-03 Submission Of Notice For The 1St Extraordinary General Meeting Of The Company -
2026-09-28 Board Meeting Outcome for Outcome Of Board Meeting Held On 28.09.2026 -
2026-09-25 Closure of Trading Window -
2026-08-14 Announcement Under Regulation 30 (LODR) - Newspaper Publication -
2026-08-13 Statement Of Deviation Or Variation For The Quarter Ended 30.06.2026 -
2026-08-13 Board Meeting Outcome for Outcome Of Board Meeting Held On 13.08.2026 -
2026-08-13 Un-Audited Financial Results For The Quarter Ended 30.06.2026 -
2026-08-10 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-08-10 Shareholder Meeting / Postal Ballot-Outcome of AGM -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹12.49, within a 52-week range of ₹10.60 to ₹23.99. The P/E ratio is -7.10 and the P/B ratio is 2.44, with earnings per unit of ₹-3.99. Market capitalisation stands at ₹27.23 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.